Role of circular RNA and its delivery strategies to cancer – An overview
Journal of Controlled Release, ISSN: 0168-3659, Vol: 356, Page: 306-315
2023
- 5Citations
- 16Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations5
- Citation Indexes5
- Captures16
- Readers16
- 16
- Mentions1
- News Mentions1
- News1
Most Recent News
New Cancer Study Findings Have Been Reported by Researchers at Northeastern University (Role of Circular Rna and Its Delivery Strategies To Cancer-an Overview)
2023 APR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Daily -- Research findings on Cancer are discussed in a new report.
Article Description
With the passage of years and the progress of research on ribonucleic acids, the range of forms in which these molecules have been observed grows. One of them, discovered relatively recently, is circular RNA - covalently closed circles (circRNA). In recent years, there has been a huge increase in the interest of researchers in this group of molecules. It entailed a significant increase in the state of knowledge about them, which in turn caused a dramatic change in their perception. Rather than seeing circular RNAs as curiosities that represent a minor information noise in a cell or a result of RNA misprocessing, they came to be regarded as a common, essential, and potentially extremely useful group of molecules. Nevertheless, the current state of the art of circRNA is full of white cards. A lot of valuable information has been obtained from high-throughput methods to study whole transcriptomes, but many issues related to circular RNAs still need to be clarified. Presumably, each answer obtained will raise several new questions. However, circRNAs have a wealth of potential applications, including therapeutic applications.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0168365923001645; http://dx.doi.org/10.1016/j.jconrel.2023.02.044; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85150771549&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/36878321; https://linkinghub.elsevier.com/retrieve/pii/S0168365923001645; https://dx.doi.org/10.1016/j.jconrel.2023.02.044
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know